مباشر

FierceBiotechFDA Commissioner Marty Makary to resign, capping turbulent tenure: report FierceBiotechKyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis Clinical OMICsLow‑Dose Digoxin Shows Benefit in Heart Failure Treatment Clinical OMICsAntibody Promotes Nerve Regeneration in Spinal Cord Injury Patients Clinical OMICsSingle Procedure Reduces Colorectal Cancer Risk Decades Later 10x Genomics News10x Genomics settles suit with rival and targets DNA sequencing startup - Life Sciences Intellectual Property Review Clinical OMICsFirst Clinical Trial for a GLP-1 Gene Therapy Greenlit in Europe BioPharma DiveFDA chief Marty Makary resigns from agency, ending tumultuous tenure Endpoints NewsEU reaches provisional deal on Critical Medicines Act Endpoints NewsFDA Commissioner Makary to resign, source says Endpoints NewsIran war disruptions begin to emerge upstream of the pharma supply chain FierceBiotechCharles River debuts AI diagnostic tool to cut down pathology timelines

Clinical OMICs ١٢ مايو ٢٠٢٦

First Clinical Trial for a GLP-1 Gene Therapy Greenlit in Europe

Fractyl Health has received regulatory approval in the Netherlands to start the first-ever clinical trial for a gene therapy to treat type 2 diabetes. The post...

Fractyl Health has received regulatory approval in the Netherlands to start the first-ever clinical trial for a gene therapy to treat type 2 diabetes. The post First Clinical Trial for a GLP-1 Gene Therapy Greenlit in Europe appeared first on Inside Precision Medicine .